MCID: NDL013
MIFTS: 41

Nodular Regenerative Hyperplasia malady

Categories: Rare diseases, Liver diseases

Aliases & Classifications for Nodular Regenerative Hyperplasia

About this section
Sources:
45NIH Rare Diseases, 51Orphanet, 65UMLS, 28ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Nodular Regenerative Hyperplasia:

Name: Nodular Regenerative Hyperplasia 45
Nodular Regenerative Hyperplasia of the Liver 45 51
Non-Cirrhotic Nodulation 45 51
Non-Cirrhotic Nodular Transformation 45
 
Miliary Hepatocellular Adenomatosis 45
Non-Cirrhotic Portal Hypertension 45
Nodular Hyperplasia 65

Characteristics:

Orphanet epidemiological data:

51

Classifications:

Orphanet: 51 
Rare hepatic diseases


External Ids:

Orphanet51 48372
ICD10 via Orphanet28 K76.8
UMLS65 C0020510

Summaries for Nodular Regenerative Hyperplasia

About this section
Wikipedia:68 Nodular regenerative hyperplasia is a form of liver hyperplasia associated with portal hypertension more...

MalaCards based summary: Nodular Regenerative Hyperplasia, also known as nodular regenerative hyperplasia of the liver, is related to systemic lupus erythematosus and hepatocellular carcinoma, and has symptoms including hypertension, hepatic failure and hepatocellular liver disease/hepatic failure. An important gene associated with Nodular Regenerative Hyperplasia is NOTCH1 (Notch 1), and among its related pathways are Neural Stem Cell Differentiation Pathways and Lineage-specific Markers and . Affiliated tissues include liver, prostate and heart, and related mouse phenotypes are tumorigenesis and respiratory system.

Related Diseases for Nodular Regenerative Hyperplasia

About this section

Graphical network of the top 20 diseases related to Nodular Regenerative Hyperplasia:



Diseases related to nodular regenerative hyperplasia

Symptoms for Nodular Regenerative Hyperplasia

About this section

Symptoms:

 51
  • hepatocellular liver disease/hepatic failure
  • chronic arterial hypertension

HPO human phenotypes related to Nodular Regenerative Hyperplasia:

id Description Frequency HPO Source Accession
1 hypertension hallmark (90%) HP:0000822
2 hepatic failure hallmark (90%) HP:0001399

Drugs & Therapeutics for Nodular Regenerative Hyperplasia

About this section

Drugs for Nodular Regenerative Hyperplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Caffeineapproved, NutraceuticalPhase 433958-08-22519
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-Trimethylxanthine
1,3,7-trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
1-Methyl-Theobromine
1-methyltheobromine
137X
1gfz
1l5q
1l7x
27602_FLUKA
2a3b
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
3,7-dihydro-1,3,7-trimethyl-1H-purine
5-26-13-00558 (Beilstein)
58-08-2
7-Methyl Theophylline
7-Methyltheophylline
7-methyltheophylline
71701-02-5
75035_FLUKA
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert
Alert-Pep
Alert-pep
Allertness Aid
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
Awake
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
BRN 0017705
BSPBio_001921
Berlin-Chemie Brand of Caffeine
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
Bristol-Myers Squibb Brand of Caffeine
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
CU-01000012617-3
Cafamil
Cafcit
Cafecon
Cafeina
Cafergot
Cafeína
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
Caffeine
Caffeine (USP)
Caffeine (natural)
Caffeine Citrate
Caffeine Pure
Caffeine [BAN:JAN]
Caffeine citrate
Caffeine solution
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeine, anhydrous
Caffeine, synthetic
Caffine
Cafipel
Caféine
Circle K Nosnooze
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum Purrum
Compound 65
Conrx Alert
D002110
D00528
DB00201
DHC Plus
DHCplus
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Diurex Ultra
Diurex WaterCaps
DivK1c_000730
Drowz Away Maximum strength
Durvitan
EINECS 200-362-1
EU-0100228
Eldiatric C
Enerjets
Equaline Stay Awake
Ercatab
Esgic
Esgic-Plus
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline Brand of Caffeine
Good Neighbor Pharmacy Stay Awake
Good Sense Stay Awake
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Health Mart Stay Awake
Healthy Accents Stay Awake
Hycomine
Hycomine Compound
I14-4386
IDI1_000730
 
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
LS-237
Lanorinal
Leader Alertness Aid
Lil Drug Store Nosnooze
Lopac-C-0750
Lopac0_000228
MEGxp0_001350
MLS001055341
MLS001056714
MLS001066409
Mateina
Mateína
Maximum Strength Caffeine
Maximum Strength Snapback Stimulant Powders
Maximum Strength Stay Awake
Medigesic Plus
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MolMap_000054
MolPort-000-730-850
Monohydrate Caffeine
Monomethyl Derivative of Theophylline
Monomethyl derivative of Theophylline
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
NCI-C02733
NCIOpen2_008255
NINDS_000730
NSC 5036
NSC5036
Nano Ppc
Natural Caffeinum
Nix Nap
No Doz
No-Doz
Nodaca
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Passauer Brand of Caffeine
Pep-Back
Pep-back Peak Performance
Pep-back Ultra
Percoffedrinol N
Percutafeine
Phensal
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-Pep
Refresh'n
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
SPECTRUM1500155
STK177283
Seid Brand of Caffeine
Smart Sense Stay Awake
Sohmed Alertness Aid
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Spectrum_001301
Stay Alert Aid
Stay Awake
Stay Awake Maximum Strength
Stay Awake Maximum strength
Stim
Sunmark Stay Awake
Synalgos-Dc
TNP00310
Teina
Thein
Theine
Theobromine ME
Theobromine Me
Theophylline ME
Theophylline Me
Theophylline, 7-methyl
Thompson Brand 1 of Caffeine
Thompson Brand 2 of Caffeine
Tirend
Topcare Stay Awake maximum strength
Tri-Aqua
Triad
UNII-3G6A5W338E
Ultra Pep-Back
Vivarin
W222402_ALDRICH
WLN: T56 BN DN FNVNVJ B1 F1 H1
Wake-Up
Wigraine
Xanthine, 1,3,7-trimethyl
ZINC00001084
bmse000206
cafeine
caffeine
caffenium
component of Cafergot
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
teina
2AnalgesicsPhase 49358
3MesalaminePhase 415289-57-6
4Calcium, DietaryPhase 44678
5Antirheumatic AgentsPhase 48496
6Analgesics, Non-NarcoticPhase 45184
7Anti-Inflammatory AgentsPhase 48478
8Anti-Inflammatory Agents, Non-SteroidalPhase 43549
9Peripheral Nervous System AgentsPhase 418510
10Calcium SupplementNutraceuticalPhase 449
11
Propranololapproved, investigationalPhase 3202525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Hemangeol
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal LA
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
 
Innopran XL
Innopran Xl
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
12Antihypertensive AgentsPhase 33618
13Neurotransmitter AgentsPhase 314795
14Vasodilator AgentsPhase 32926
15Anti-Arrhythmia AgentsPhase 32371
16Adrenergic beta-AntagonistsPhase 3979
17Adrenergic AgentsPhase 34204
18Adrenergic AntagonistsPhase 31253
19
Epinephrineapproved83451-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenaclick
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
Auvi-q
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine bitartrate
Epinephrine chloride
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr
Epipen Jr.
Epipen Jr. Auto-Injector
Epipen jr
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
 
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
Primatene Mist Refill
Prime Asthma Relief
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
20
Etomidateapproved5733125-97-236339, 667484
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Etomidate
(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-etomidate
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
(d)-Etomidate
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester
1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester
15301-65-2
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
33125-97-2
AC-5898
AC1L1VLF
AC1Q34BV
AC1Q64LP
AKOS000548952
Absele
Amidate
Amidate (TN)
Amidate (pharmaceutical)
Amidate, Etomidate
BAS 01947657
BRN 0665833
C07522
C14H16N2O2
CHEBI:129025
CHEMBL23731
CID36339
CPD000010931
D-Etomidate
D005045
D00548
 
DB00292
EINECS 251-385-9
Ethnor
Ethomidate
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
Etomidate
Etomidate (USAN/INN)
Etomidate [USAN:BAN:INN]
Etomidato
Etomidato [INN-Spanish]
Etomidatum
Etomidatum [INN-Latin]
Etomidic acid
HMS1571A04
HMS1612G10
HMS2093P17
Hypnomidate
LS-78232
MLS000034952
MLS001240191
MolPort-000-917-569
Prestwick0_001041
Prestwick1_001041
Prestwick2_001041
R 16659
R 26490
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-26490
R26490
Radenarcon
Radenarkon
S1329_Selleck
SAM002548930
SBB066197
SMR000010931
SPBio_002901
UNII-Z22628B598
ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
21Liver Extracts3572
22Racepinephrine834
23Epinephryl borate834
24Hypnotics and Sedatives2032
25Anesthetics, Intravenous1943
26Anesthetics7385
27Anesthetics, General2274
28Central Nervous System Depressants10016

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Clinical Management of Childhood Intestinal Lymphoid Nodular HyperplasiaRecruitingNCT01789294Phase 4
2Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH)CompletedNCT01000779Phase 3
3Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal HypertensionCompletedNCT02635815
4Quantitative Real-time Ultrasound Elastography for Characterisation of Liver TumorsCompletedNCT02156700
5Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy OutcomeCompletedNCT01826617
6Superb Microvascular Imaging in Focal Nodular HyperplasiaRecruitingNCT02737865
7Natural History of Noncirrhotic Portal HypertensionRecruitingNCT02417740
8Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver LesionsRecruitingNCT01329458
9Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
10Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver MassesRecruitingNCT00828607
1111C-Metomidate PET Versus Adrenal Vein Sampling in Primary AldosteronismActive, not recruitingNCT01567111
12Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.Enrolling by invitationNCT02767206

Search NIH Clinical Center for Nodular Regenerative Hyperplasia

Genetic Tests for Nodular Regenerative Hyperplasia

About this section

Anatomical Context for Nodular Regenerative Hyperplasia

About this section

MalaCards organs/tissues related to Nodular Regenerative Hyperplasia:

33
Liver, Prostate, Heart, Lung, Endothelial, Bone, T cells

Animal Models for Nodular Regenerative Hyperplasia or affiliated genes

About this section

MGI Mouse Phenotypes related to Nodular Regenerative Hyperplasia:

38 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020069.2F3, GFER, NOTCH1, NOTCH2
2MP:00053889.0EFNB2, ITPA, NOTCH1, NOTCH2
3MP:00107718.7EFNB2, F3, ITPA, NOTCH1, NOTCH2
4MP:00053698.5EFNB2, F3, ITPA, NOTCH1, NOTCH2
5MP:00053858.2EFNB2, F3, ITPA, NOTCH1, NOTCH2
6MP:00053848.1EFNB2, F3, GFER, ITPA, NOTCH1, NOTCH2
7MP:00053897.9EFNB2, ITPA, NOTCH2, PCNA, TPMT
8MP:00053877.3EFNB2, F3, GFER, NOTCH1, NOTCH2, PCNA
9MP:00053976.9EFNB2, F3, ITPA, NOTCH1, NOTCH2, PCNA
10MP:00107686.5EFNB2, F3, GFER, ITPA, NOTCH1, NOTCH2
11MP:00053786.5EFNB2, F3, GFER, ITPA, NOTCH1, NOTCH2

Publications for Nodular Regenerative Hyperplasia

About this section

Articles related to Nodular Regenerative Hyperplasia:

(show top 50)    (show all 233)
idTitleAuthorsYear
1
Lumbar puncture pressures during childhood in 262 children with craniosynostosis. (27178233)
2016
2
A strategy focused on MAPT, APP, NCSTN and BACE1 to build blood classifiers for Alzheimer's disease. (25863267)
2015
3
Re: Peripheral hypertrophic subepithelial corneal degeneration - clinical and histopathological features. (25809296)
2015
4
Mixed Phenotype Acute Leukemia with Low Hypodiploidy in a Pediatric Patient. (26525596)
2015
5
Predicting mortality from head injury: experience of Sancti SpA-ritus province, Cuba. (23934424)
2013
6
The esophagitis to adenocarcinoma sequence; the role of inflammation. (23994342)
2013
7
B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells. (24124529)
2013
8
Clinical characteristics of adult-onset actinic prurigo in Asians: a case series. (24177610)
2013
9
Networking the host immune response in Plasmodium vivax malaria. (23433077)
2013
10
A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 I1g/kg, 75 I1g/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience. (23470649)
2013
11
Inhibition of postprandial hyperglycemia by either an insulin-dependent or -independent drug reduces the expression of genes related to inflammation in peripheral leukocytes of OLETF rats. (24200798)
2013
12
Three-dimensional echocardiography for the evaluation of left ventricular noncompaction. (22658560)
2012
13
Expression of CD147 is associated with prostate cancer progression. (21328337)
2012
14
Diaphragm valves reduce gastroesophageal reflux following cardiomyotomy for patients with achalasia. (23008993)
2012
15
Research progression of LDLR mutations in Chinese Familial hypercholesterolemia]. (21377952)
2011
16
Chagas disease: transcriptomic recovery in animal models after transplantation of bone marrow cells. (21577049)
2011
17
The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. (21678294)
2011
18
Craniosynostosis associated with neural tube defects: is there a causal association? (22572596)
2011
19
Association of the 8473T>C cyclooxygenase-2 (COX-2) gene polymorphism with lung cancer risk in Asians. (21198273)
2010
20
Crystallization and preliminary X-ray characterization of the Skp1-Fbg3 complex. (20057081)
2010
21
EEG features and epilepsy in MECP2-mutated patients with the Zappella variant of Rett syndrome. (20153689)
2010
22
Re: Pericardial effusion impending tamponade: a look beyond Beck's triad. (19497471)
2009
23
Neonatal airway obstruction caused by rapidly growing nasopharyngeal teratoma. (19659708)
2009
24
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. (19393842)
2009
25
Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa. (20004170)
2009
26
Cyclic neutropenia: a de novo case and treatment with G-CSF]. (19268636)
2009
27
Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. (18365315)
2008
28
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. (18852127)
2008
29
BRCA1 mutations and prostate cancer in Poland. (18090912)
2008
30
Statins: multiple mechanisms of action in the ischemic brain. (17519364)
2007
31
Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity. (15870704)
2005
32
Carcinosarcoma of the lacrimal gland arising from a pleomorphic adenoma. (16086968)
2005
33
Systemic low-grade inflammation and risk of coronary heart disease: results from the MONICA/KORA Augsburg cohort studies. (16032519)
2005
34
Egghead and brainiac are essential for glycosphingolipid biosynthesis in vivo. (15611100)
2005
35
Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. (15498832)
2005
36
Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. (15475461)
2004
37
Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea. (12650964)
2003
38
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents. (12565970)
2003
39
Arrhythmogenic right ventricular dysplasia/cardiomyopathy. (12569915)
2003
40
ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control. (14728069)
2003
41
Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease. (11044563)
2000
42
Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase. (10953206)
2000
43
Transcardiac extraction of circulating endothelin-1 across the failing heart. (11009270)
2000
44
Intestinal volvulus following laparoscopic cholecystectomy. (11757542)
1999
45
Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders. (9577842)
1998
46
Trichinosis. Still a public health threat. (7777441)
1995
47
Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. (1387544)
1992
48
Post-traumatic acalculous cholecystitis on a neurosurgical service. (6828228)
1983
49
Plasma glucose, hydrocortisone, and insulin levels in acute swine erysipelas. (5121720)
1971
50
Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. (5456802)
1970

Variations for Nodular Regenerative Hyperplasia

About this section

Expression for genes affiliated with Nodular Regenerative Hyperplasia

About this section
Search GEO for disease gene expression data for Nodular Regenerative Hyperplasia.

Pathways for genes affiliated with Nodular Regenerative Hyperplasia

About this section

Pathways related to Nodular Regenerative Hyperplasia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6NOTCH1, NOTCH2
2
Show member pathways
9.6NOTCH1, NOTCH2
39.6NOTCH1, NOTCH2

GO Terms for genes affiliated with Nodular Regenerative Hyperplasia

About this section

Biological processes related to Nodular Regenerative Hyperplasia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Notch signaling involved in heart developmentGO:00613149.9NOTCH1, NOTCH2
2pulmonary valve morphogenesisGO:00031849.8NOTCH1, NOTCH2
3regulation of developmental processGO:00507939.8NOTCH1, NOTCH2
4positive regulation of cell migrationGO:00303359.8F3, NOTCH1
5Notch receptor processingGO:00072209.5NOTCH1, NOTCH2
6Notch signaling pathwayGO:00072199.3NOTCH1, NOTCH2

Sources for Nodular Regenerative Hyperplasia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet